WallStreetZenWallStreetZen

NASDAQ: FRNM
Freenome Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FRNM

Based on 5 analysts offering 12 month price targets for Freenome Inc

Min Forecast
$17.00+33.65%
Avg Forecast
$18.00+41.51%
Max Forecast
$21.00+65.09%

Should I buy or sell FRNM stock?

Based on 5 analysts offering ratings for Freenome Inc.

Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although FRNM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates FRNM as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their FRNM stock forecasts and price targets.

FRNM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-20
lockedlocked$00.00+00.00%2026-08-18
lockedlocked$00.00+00.00%2026-08-17
lockedlocked$00.00+00.00%2026-08-17
lockedlocked$00.00+00.00%2026-08-14

1 of 1

Forecast return on equity

Is FRNM forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is FRNM forecast to generate an efficient return on assets?

Company
-34.38%
Industry
12.02%
FRNM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FRNM earnings per share forecast

What is FRNM's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$2.84
Avg 2 year Forecast
-$2.01
Avg 3 year Forecast
-$1.41

FRNM revenue forecast

What is FRNM's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$128.5M
Avg 2 year Forecast
$111.6M
Avg 3 year Forecast
$236.9M
FRNM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FRNM revenue growth forecast

How is FRNM forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
114.28%
Industry
7.61%
Market
14.33%
FRNM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FRNM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FRNM vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
FRNM$12.72$18.00+41.51%Strong Buy
OPK$1.63$4.00+145.40%Strong Buy
PSNL$15.88$14.63-7.90%Hold
CSTL$33.30$42.33+27.13%Strong Buy
NEO$16.69$20.00+19.83%Strong Buy
View Top Diagnostic & Research Stocks

Freenome Stock Forecast FAQ

Is Freenome Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: FRNM) stock is to Strong Buy FRNM stock.

Out of 5 analysts, 4 (80%) are recommending FRNM as a Strong Buy, 1 (20%) are recommending FRNM as a Buy, 0 (0%) are recommending FRNM as a Hold, 0 (0%) are recommending FRNM as a Sell, and 0 (0%) are recommending FRNM as a Strong Sell.

If you're new to stock investing, here's how to buy Freenome stock.

What is FRNM's earnings growth forecast for 2026-2028?

(NASDAQ: FRNM) Freenome's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 23.3%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 67.03%.

Freenome's earnings in 2026 is -$283,580,555.On average, 5 Wall Street analysts forecast FRNM's earnings for 2026 to be -$303,834,518, with the lowest FRNM earnings forecast at -$501,332,306, and the highest FRNM earnings forecast at -$179,796,404. On average, 5 Wall Street analysts forecast FRNM's earnings for 2027 to be -$215,413,215, with the lowest FRNM earnings forecast at -$233,885,155, and the highest FRNM earnings forecast at -$174,177,766.

In 2028, FRNM is forecast to generate -$150,643,701 in earnings, with the lowest earnings forecast at -$173,054,039 and the highest earnings forecast at -$113,496,480.

What is FRNM's revenue growth forecast for 2026-2028?

(NASDAQ: FRNM) Freenome's forecast annual revenue growth rate of 114.28% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.33%.

Freenome's revenue in 2026 is $34,631,000.On average, 6 Wall Street analysts forecast FRNM's revenue for 2026 to be $13,756,565,333, with the lowest FRNM revenue forecast at $11,243,696,545, and the highest FRNM revenue forecast at $15,282,694,333. On average, 6 Wall Street analysts forecast FRNM's revenue for 2027 to be $11,946,828,910, with the lowest FRNM revenue forecast at $3,477,134,026, and the highest FRNM revenue forecast at $19,901,749,567.

In 2028, FRNM is forecast to generate $25,349,152,519 in revenue, with the lowest revenue forecast at $16,012,582,116 and the highest revenue forecast at $33,746,072,669.

What is FRNM's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: FRNM) forecast ROA is -34.38%, which is lower than the forecast US Diagnostics & Research industry average of 12.02%.

What is FRNM's Price Target?

According to 5 Wall Street analysts that have issued a 1 year FRNM price target, the average FRNM price target is $18.00, with the highest FRNM stock price forecast at $21.00 and the lowest FRNM stock price forecast at $17.00.

On average, Wall Street analysts predict that Freenome's share price could reach $18.00 by Aug 20, 2027. The average Freenome stock price prediction forecasts a potential upside of 41.51% from the current FRNM share price of $12.72.

What is FRNM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: FRNM) Freenome's current Earnings Per Share (EPS) is -$10.72. On average, analysts forecast that FRNM's EPS will be -$2.84 for 2026, with the lowest EPS forecast at -$4.68, and the highest EPS forecast at -$1.68. On average, analysts forecast that FRNM's EPS will be -$2.01 for 2027, with the lowest EPS forecast at -$2.19, and the highest EPS forecast at -$1.63. In 2028, FRNM's EPS is forecast to hit -$1.41 (min: -$1.62, max: -$1.06).

What is FRNM's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: FRNM) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.